Small Molecules for Hearing Loss
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT06521190
ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 15, 2023
Completion: Sep 30, 2025
Loading map...